Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Reevaluation Of Spectrum Pharmaceuticals
Seeking Alpha
Thursday, April 12, 2012 - 12:24pm
tags:
Spectrum Pharmaceuticals, Allon Therapeutics
[video] Eli Lilly CEO on Profit Pipeline in China
CNBC
Thursday, April 12, 2012 - 12:22pm
tags:
John Lechleiter, China, Eli Lilly
Pivotal FDA Decision Upcoming For Alexza
Seeking Alpha
Thursday, April 12, 2012 - 11:37am
tags:
FDA, Alexza, Adasuve, schizophrenia, bipolar disorder
Watson, Actavis aim for deal by end-April -sources
Reuters
Thursday, April 12, 2012 - 11:35am
tags:
Actavis, Watson Pharmaceuticals, M&A
Gilead Bets on Hepatitis C Data to Back Pharmasset Deal
Bloomberg
Thursday, April 12, 2012 - 11:35am
tags:
Gilead, hepatitis C, Pharmasset, BMS-790052, GS-7977
Roche Sales Slip, But Hints at Willingness to Lift Illumina Offer
FOX Business
Thursday, April 12, 2012 - 11:32am
tags:
Roche, Illumina, earnings, M&A
AstraZeneca Needs the Right Formula
Motley Fool
Thursday, April 12, 2012 - 11:31am
tags:
AstraZeneca
AstraZeneca launches new blood pressure drug Dutoprol, announces marketing strategy
Yahoo/AP
Thursday, April 12, 2012 - 11:29am
tags:
Dutoprol, AstraZeneca, antihypertensives
Sexual side effect warnings added to Merck drugs
Reuters
Thursday, April 12, 2012 - 11:28am
tags:
warnings, Merck, baldness, enlarged prostate, Propecia, Proscar
Johnson & Johnson First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thursday, April 12, 2012 - 11:27am
tags:
earnings, JNJ
Pfizer and its Competition in 2012
Motley Fool
Thursday, April 12, 2012 - 11:26am
tags:
Pfizer, bapineuzumab, solanezumab, Eli Lilly, tofacitinib, Vertex Pharmaceuticals, Incyte
Zeltia Plans Europe Drug Sales Force in Market-Share Push
Bloomberg
Thursday, April 12, 2012 - 11:24am
tags:
Zeltia, Europe, Yondelis
Arkansas judge fines J&J $1.1B in Risperdal case
Yahoo/AP
Wednesday, April 11, 2012 - 12:00pm
tags:
JNJ, fines, Risperdal
U.S. court invalidates two Sanofi Taxotere patents
Reuters
Wednesday, April 11, 2012 - 11:59am
tags:
patents, Sanofi, Taxotere
Sucampo says "disappointed" by Takeda's performance
The Fly on the Wall
Wednesday, April 11, 2012 - 11:56am
tags:
Sucampo, Takeda, Amitiza
Vertex: Watch New Hepatitis C Drug
Seeking Alpha
Wednesday, April 11, 2012 - 11:46am
tags:
hepatitis C, Vertex, Incivek, Abbott Laboratories, Bristol-Myers Squibb, Gilead
Handicapping The Obesity Race
Seeking Alpha
Wednesday, April 11, 2012 - 10:59am
tags:
obesity, Vivus, Arena Pharmaceuticals, Orexigen
Arrowhead Research purchases privately held Alvos Therapeutics
Yahoo/AP
Wednesday, April 11, 2012 - 10:58am
tags:
Arrowhead, Alvos Therapeutics, M&A
6 Biotech Stocks With Huge Potential In May
Seeking Alpha
Wednesday, April 11, 2012 - 10:56am
tags:
taliglucerase alfa, Protalix BioTherapeutics, Alexza, Adasuve, Regeneron, Arcalyst, lorcaserin, Arena Pharmaceuticals, Quad, Truvada, Gilead, Talon Therapeutics, Marqibo
Abbott Sues Boehringer's Roxane Over Patents for Norvir
Bloomberg
Wednesday, April 11, 2012 - 10:53am
tags:
Boehringer, Roxane Laboratories, patents, Norvir, lawsuits, Abbott Laboratories, HIV

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.